4.7 Letter

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Antoine Guilmot et al.

Summary: Evidence of immune-mediated neurological syndromes in COVID-19 patients is limited. However, this study found that in a small subset of patients with neurological manifestations, CSF pleocytosis and detection of anti-GD1b and anti-Caspr2 antibodies may suggest secondary autoimmunity potentially induced by SARS-CoV-2 infection.

JOURNAL OF NEUROLOGY (2021)

Article Medicine, Research & Experimental

SARS-CoV-2 infection as a trigger of autoimmune response

Maria C. Sacchi et al.

Summary: The study revealed a possible link between COVID-19 infection and autoimmune response, with patients exhibiting autoimmune response having poorer prognoses. Therefore, checking for autoimmune markers in COVID-19 patients is crucial for treatment decisions.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Article Immunology

Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms

Gerd Wallukat et al.

Summary: Within a sample of long-term COVID-19 recovered patients, various GPCR-fAABs autoantibodies were detected, with some antibodies causing positive chronotropic effects on cardiac cells while affecting the nervous and cardiovascular systems significantly.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)